A 52-year-old man with known type 2 diabetes is reviewed in clinic. His latest HbA1c is 68 mmol/mol despite lifestyle modifications and metformin 1g B...

Question

A 52-year-old man with known type 2 diabetes is reviewed in clinic. His latest HbA1c is 68 mmol/mol despite lifestyle modifications and metformin 1g BD. His eGFR is >60 mL/min/1.73m² and BMI is 31 kg/m². He has no history of cardiovascular disease. According to NICE NG28, what is an appropriate next agent to add?

Accepted Answer

Empagliflozin (an SGLT2 inhibitor)

Answer

Sitagliptin (a DPP-4 inhibitor)

Answer

Pioglitazone

Answer

Gliclazide (a sulfonylurea)

Answer

Liraglutide (a GLP-1 mimetic)

ukmla MCQ (SBA): Type 2 Diabetes Management